Inventor

Christopher M. Tegley

Inventor

Thousand Oaks, CA, US

Overview

1997–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 81 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

C07DHeterocyclic compounds36%

A61KPreparations for medical, dental or toiletry purposes17%

C07CAcyclic or carbocyclic compounds2%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

C04BLime, magnesia1%

C07BGeneral methods of organic chemistry1%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%

C07KPeptides1%

G01CMeasuring distances, levels or bearings1%

PatentTitleYear

11,090,304KRAS G12C inhibitors and methods of using the same2021 11,053,226KRAS G12C inhibitors and methods of using the same2021 10,532,042KRAS G12C inhibitors and methods of using the same2020 10,344,060Potent and selective inhibitors of Nav1.72019 9,636,418'Potent and selective inhibitors of NAV1.7'2017 8,796,266'Cyclothiocarbamate derivatives as progesterone receptor modulators'2014 8,735,384'Amino heteroaryl compounds as beta-secretase modulators and methods of use'2014 8,686,011'Inhibitors of 11-Î²-hydroxy steroid dehydrogenase type 1'2014 8,541,592'Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1'2013 8,476,262'Cyanopyrroles'2013 8,466,146'Cyclothiocarbamate derivatives as progesterone receptor modulators'2013 8,431,563'Compounds that interact with glucokinase regulatory protein for the treatment of diabetes'2013 8,329,690'Cyclothiocarbamate derivatives as progesterone receptor modulators'2012 8,097,620'Diazaquinolones that inhibit prolyl hydroxylase activity'2012 8,048,892'Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'2011 8,017,626'Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof'2011 8,012,968'Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof'2011 7,928,139'Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'2011 7,846,924'Cyanopyrroles'2010 7,807,700'Inhibitors of 11-Î²-hydroxy steroid dehydrogenase type 1'2010 7,728,130'Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity'2010 7,645,761'Indoline derivatives'2010 7,635,715'Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'2009 7,569,564'Cyclothiocarbamate derivatives as progesterone receptor modulators'2009 7,488,822'Cyclocarbamate derivatives as progesterone receptor modulators'2009 7,390,820'Substituted quinolinone derivatives and methods of use'2008 7,320,992'Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use'2008 7,253,203'Indoline derivatives'2007 7,253,196'Inhibitors of 11-Î²-hydroxy steroid dehydrogenase type 1'2007 7,196,104'Thiazolyl urea compounds and methods of uses'2007 7,091,234'Thio-oxindole derivatives'2006 7,084,168'Indoline derivatives'2006 7,081,457'Cyclothiocarbamate derivatives as progesterone receptor modulators'2006 6,982,261'Cyanopyrroles'2006 6,946,454'Thio-oxindole derivatives'2005 6,841,568'Thio-oxindole derivatives'2005 6,835,744'3,3-substituted indoline derivatives'2004 6,794,373'Contraceptive methods using benzimidazolones'2004 6,759,408'Combination regimens using progesterone receptor modulators'2004 6,713,478'Cyclocarbamate derivatives as progesterone receptor modulators'2004 6,696,459'Steroid receptor modulator compounds and methods'2004 6,693,103'1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators'2004 6,645,990'Thiazolyl urea compounds and methods of uses'2003 6,608,068'Indoline derivatives'2003 6,583,145'Thio-oxindole derivatives'2003 6,566,358'Cyclocarbamate derivatives as progesterone receptor modulators'2003 6,566,372'Bicyclic androgen and progesterone receptor modulator compounds and methods'2003 6,562,857'Cyanopyrroles'2003 6,544,970'Cyclic regimens utilizing indoline derivatives'2003 6,521,657'Thio-oxindole derivatives'2003 6,509,334'Cyclocarbamate derivatives as progesterone receptor modulators'2003 6,503,939'Combination regimens using 3,3-substituted indoline derivatives'2003 6,498,154'Cyclic regimens using quinazolinone and benzoxazine derivatives'2002 6,462,032'Cyclic regimens utilizing indoline derivatives'2002 6,448,405'Steroid receptor modulator compounds and methods'2002 6,444,668'Combination regimens using progesterone receptor modulators'2002 6,441,019'Cyclocarbamate and cyclic amide derivatives'2002 6,436,929'Cyclothiocarbamate derivatives as progesterone receptor modulators'2002 6,423,699'Combination therapies using benzimidazolones'2002 6,417,214'3,3-substituted indoline derivatives'2002 6,407,101'Cyanopyrroles'2002 6,399,593'Cyclic regimens using cyclic urea and cyclic amide derivatives'2002 6,391,907'Indoline derivatives'2002 6,380,235'Benzimidazolones and analogues'2002 6,380,178'Cyclic regimens using cyclocarbamate and cyclic amide derivatives'2002 6,369,056'Cyclic urea and cyclic amide derivatives'2002 6,358,947'Tetracyclic progesterone receptor modulator compounds and methods'2002 6,358,948'Quinazolinone and benzoxazine derivatives as progesterone receptor modulators'2002 6,355,648'Thio-oxindole derivatives'2002 6,339,098'2,1-benzisothiazoline 2,2-dioxides'2002 6,329,416'Combination regimens using 3,3-substituted indoline derivatives'2001 6,319,912'Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides'2001 6,306,851'Cyclocarbamate and cyclic amide derivatives'2001 6,093,821'Process for preparing steroid receptor modulator compounds'2000 5,994,544'Steroid receptor modulator compounds and methods'1999 5,696,133'Steroid receptor modulator compounds and methods'1997 5,696,127'Steroid receptor modulator compounds and methods'1997 5,693,646'Steroid receptor modulator compounds and methods'1997 5,693,647'Steroid receptor modulator compounds and methods'1997 5,688,810'Steroid receptor modulator compounds and methods'1997 5,688,808'Steroid receptor modulator compounds and methods'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2006Patents assigned to LIGAND PHARM INC (45)· patent assignee history

1997–2004Based in San Diego, CA, US· patent location history

2001–2003Patents assigned to AMERICAN HOME PROD (14)· patent assignee history

2001–2021Based in Thousand Oaks, CA, US· patent location history

2002–2010Patents assigned to WYETH CORP (26)· patent assignee history

2002Based in Thousands Oaks, CA, US· patent location history

2003–2021Patents assigned to AMGEN INC (21)· patent assignee history

2010–2014Patents assigned to WYETH LLC (5)· patent assignee history

2021Based in Daly City, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
LIGAND PHARM INC	45	1997–2006
WYETH CORP	26	2002–2010
AMGEN INC	21	2003–2021
AMERICAN HOME PROD	14	2001–2003
WYETH LLC	5	2010–2014

Locations

Location	Patents	Span
Thousand Oaks, California, US	67	2001–2021
San Diego, California, US	11	1997–2004
Thousands Oaks, California, US	2	2002
Daly City, California, US	1	2021